A researcher in a lab looking at a tablet.

Category: Clinical Trials

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Clinical Trials Can Help Those with ALK Lung Cancer Get State of the Art Treatment

    In this newsletter, we pay tribute to Linnea Olson, a 17-year ALK-positive lung cancer survivor. We lost her in November of 2021, but her legacy as a creative, kind, and

    Read More

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Announcing ALK Positive ClinWiki, A Better Way to Search for Clinical Trials

    The main register of worldwide clinical trials is ClinicalTrials.gov, which has a search function. But searching for “ALK lung cancer” on ClinicalTrials.gov is a frustrating exercise. Oddly, you will be

    Read More

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    ALK-positive Clinical Trials are not just for people in the United States

    If you are at diagnosis or at a juncture in treatment, an ALK-positive lung cancer clinical trial may help you receive state of the art treatment. Although many clinical trials

    Read More

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Are there any new Clinical Trials recruiting for ALK-positive lung cancer?

    Clinical trials for more advanced ALK inhibitors, like the TPX-131 study recruiting in Australia and the US, are exciting because they improve on drugs we know work well for ALK-positive

    Read More

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Update on Clinical Trials currently recruiting for ALK-positive lung cancer

    A new ALK inhibitor starts its clinical trials this month! TPX-0131 is an TKI ALK inhibitor designed to overcome multiple ALK resistance mutations. This first-in-human trial for ALK-positive lung cancer

    Read More

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Update on ALK Clinical Trials currently recruiting and a caregiver’s perspective on why treatment at an NCI cancer center prolongs survival

    Like all trips to the emergency room, this one was unexpected. But my husband was shocked and overwhelmed to hear he had stage 4 lung cancer. With tumors throughout his

    Read More

  • ,

    ALK Positive funds two new clinical trials

    November is Lung Cancer Awareness Month, which is a good time to reflect on our successes as an organization. In 2020, we were excited to announce that the ALK Positive/LUNGevity

    Read More

  • ,

    ALK-positive clinical trials & interview with multi-clinical ALK trial participant, Hazel Senz

    Member Hazel Senz from Golden, CO shares her experiences from participating in multiple ALK clinical trials and how they have affected the course of her disease. Hazel Senz has been

    Read More

  • Case Study: successful re-use of Brigatinib after Lorlatinib

    Case study: Successful re-use of Brigatinib after Lorlatinib The patient in this case study was diagnosed with ALK-positive lung cancer in 2005 and had disease progression on several occasions.  Chemotherapy

    Read More